Riik: Ameerika Ühendriigid
keel: inglise
Allikas: NLM (National Library of Medicine)
OXYTOCIN (UNII: 1JQS135EYN) (OXYTOCIN - UNII:1JQS135EYN)
Cantrell Drug Company
INTRAVENOUS
PRESCRIPTION DRUG
unapproved drug other
OXYTOCIN - OXYTOCIN INJECTION, SOLUTION CANTRELL DRUG COMPANY _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- OXYTOCIN 30 USP UNITS ADDED TO 0.9% SODIUM CHLORIDE 500 ML BAG OXYTOCIN oxytocin injection, solution Cantrell Drug Company PRODUCT INFORMATION PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:52533-0 56 ROUTE OF ADMINISTRATION INTRAVENOUS ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH O XYTO CIN (UNII: 1JQS135EYN) (OXYTOCIN - UNII:1JQS135EYN) OXYTOCIN 30 [USP'U] in 50 0 mL INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH SO DIUM CHLO RIDE (UNII: 451W47IQ8 X) 4.5 g in 50 0 mL WA TER (UNII: 0 59 QF0 KO0 R) OTHER INGREDIENTS INGREDIENT KIND INGREDIENT NAME QUANTITY May co ntain ACETIC ACID (UNII: Q40 Q9 N0 6 3P) May co ntain SO DIUM HYDRO XIDE (UNII: 55X0 4QC32I) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:52533-0 56 -30 50 0 mL in 1 BAG MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 10 /20 /20 11 LABELER - Cantrell Drug Company (035545763) Revised: 12/2014 Lugege kogu dokumenti